Chemotherapy dose standardisation: Key therapeutic topic [KTT22]
This document summarises the evidence-base on chemotherapy dose standardisation. It is a key therapeutic topic which has been identified to support medicines optimisation. It is not formal NICE guidance.
https://www.nice.org.uk/advice/ktt22
Thanks to all the BOPA members who have contributed to the implementation support documents.
Dear BOPA Members, We are pleased to share an important update to the BOPA Standards for the Pharmacy Verification of Prescriptions for Cancer Medicines (Version 5.0, 3 June 2025). A…
We’re excited to announce the next Pharmacists’ Essential Guide to Haematology course, hosted by the UCLH Cancer Academy. This two-day course is designed specifically for pharmacists starting their haem-oncology journey,…
Dear Oncology/Haematology Pharmacist, You are invited to participate in a survey exploring the factors that influence UK-registered pharmacists’ use and the development of ChemoCare Electronic Prescribing system (EPS) for systemic…
Elaine Vickers, PhD, creator of the UTIC course, has also produced a playlist of ten short videos on “Cancer Basics”, which is freely available on YouTube. In these videos, Elaine…
The 28th BOPA Annual Conference in 2025 will be held at the ICC Belfast on 3-5 October 2025.
Check out the latest information here: Latest Conference 2025 – BOPA
Everything you need to know
